Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Stem Cells in Drug Discovery

Daniel Gaffney's Biography

Daniel Gaffney, Group Leader, Wellcome Trust Sanger Institute

Daniel Gaffney's research focusses on identifying genetic changes that alter cell phenotypes and functions. His research combines a mixture of computational and experimental techniques to map and characterise genetic variants that alter cellular traits.

Daniel earned his PhD in evolutionary genetics from Edinburgh University in 2006 under the supervision of Dr Peter Keightley. His graduate research used computational methods to study variation in the mutation rate and natural selection in noncoding DNA. From 2006 to 2008 he pursued a postdoc with Dr Jacek Majewski in McGill University and Genome Quebec Genome Centre, where he worked on the evolution of transcriptional regulation and alternative splicing in mammals. From 2008 until 2011 he worked on population genetic variation in gene expression and regulation with Dr Jonathan Pritchard at the University of Chicago.

In July 2011 Daniel started as a Career Development Fellowship Group Leader at the Wellcome Trust Sanger Institute and was promoted to Group Leader in October 2015. The long-term goal of the group is to understand the molecular and cellular consequences of genetic changes in gene regulatory regions. His research combines statistical genetics with high-throughput experimental techniques in human cells to address these questions. Much of the group's recent research has been focussed on using human induced pluripotent stem cells (hIPSCs) and cells derived from hIPSCs as model systems to map and characterise human noncoding genetic changes.

Daniel Gaffney Image

Mapping Functional Effects of Common Genetic Variants in IPS Derived Immune Cells

Tuesday, 7 March 2017 at 15:00

Add to Calendar ▼2017-03-07 15:00:002017-03-07 16:00:00Europe/LondonMapping Functional Effects of Common Genetic Variants in IPS Derived Immune

I will present the latest results from our work on the Human Induced Pluripotent Stem Cell Initative (, which aims to generate large numbers of IPSCs from healthy individuals and disease volunteers. I will also discuss some of our work using HIPSCI lines to study a range of cell lineage.

Add to Calendar ▼2017-03-06 00:00:002017-03-07 00:00:00Europe/LondonStem Cells in Drug